July 10, 2026 · Form 4 insider transaction
Raday Gilead bought 28,150,000 shares of RedHill Biopharma Ltd. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Each ADS is convertible at any time, at the holder's election, for no consideration and has no expiration date.